Key facts
- This page summarizes Dirk Huebner's Form 4 filing for Aptevo Therapeutics Inc. (APVO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Aug 2026, 21:35.
Dirk Huebner - 06 Aug 2026 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)
- Reporting relationship
- SVP, CMO
- Issuer ticker
- APVO
- Reported as of
- 06 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Aug 2026, 21:35:04 UTC
- Prior SEC filing
- 08 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ SoYoung Kwon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dirk Huebner filed Form 4 for Aptevo Therapeutics Inc. (APVO) on 10 Aug 2026.
Change
- Previous filing in this sequence was filed on 08 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001760345
Primary reporting owner
Huebner Dirk
- Relationship
- SVP, CMO
- Address
- 2401 4TH AVENUE, SUITE 1050, SEATTLE
- Signature
- /s/ SoYoung Kwon, Attorney-in-Fact
- Signature date
- 10 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APVO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +638
- Change %
- Price
- Shares after
- 638
- Date
- 06 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
APVO
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -156
- Change %
- -24%
- Price
- $4.07*
- Shares after
- 482
- Date
- 06 Aug 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APVO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -638
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 638
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
Footnote F2
Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs.
Footnote F3
On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant.